Ozempic is driving up the cost of your health care, whether you can get your hands on it or not

[ad_1] About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get…

These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments

[ad_1] The lucrative market for weight loss drugs won’t stay a duopoly forever. With billions at…

Why half of all workers may struggle to get weight-loss drug health insurance coverage

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Nutritional needs are ‘shifting’ amid rise of weight loss drugs, says Nestle CEO

[ad_1] The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides…

Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts

[ad_1] As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would…

This under-the-radar biotech could be the next way to play the obesity drug boom

[ad_1] The lucrative market for obesity drugs is dominated by two players right now, but Structure…

Newseum Global